跳至主要内容
临床试验/ITMCTR2200006653
ITMCTR2200006653尚未招募未知

Chronic kidney disease (CKD) proprietary Chinese medicine diagnosis and syndrome differentiation optimization scheme in the community of popularization and application

BEIJING HOSPITAL OF TRADITIONAL CHINESE MEDICINE0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • ? Patients with ckD3-4 stage diagnosis;
  • ? Aged between 18 and 75;
  • ? Did not receive renal replacement therapy;
  • ? Those who voluntarily accept treatment and sign informed consent.

排除标准

  • ? Recent (within 4 weeks) severe infection, severe anemia, electrolyte disorder and other complications;
  • ? Patients with severe diseases of heart, brain, liver and hematopoietic system (cerebral infarction, cerebral hemorrhage, transient ischemic attack, myocardial infarction, unstable angina pectoris, heart failure, and elevation of aminotransferase to more than 2 times of the upper limit of normal range) had occurred in 3 months before enrollment;
  • ? with acute kidney injury; Oliguria or no urine, severe edema, large pleural effusion, abdominal effusion;
  • ? Patients with kidney disease secondary to various tumors;
  • ? With wasting diseases such as tuberculosis or a history of mental diseases;
  • ? women who are pregnant or preparing for pregnancy or lactation;
  • Within 12 weeks, he used glucocorticoid, immunosuppressant and Tripterygium wilfordii preparation.
  • (8) patients known to be allergic to the drugs used;
  • ? Those who are participating in other interventional clinical trials or have participated in other clinical trials within 12 weeks;

研究者

相似试验